Advertisement

Product › Details
virostatic agent
![]() |
Next higher product group | anti-infective drug |
Status | 1998-01-01 sales existent | |
Record changed: 2022-03-03 |
Advertisement
![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
More documents for virostatic agent
- [1] ReViral Ltd.. (4/7/22). "Press Release: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates". New York, NY, London & Research Triangle Park, NC....
- [2] Meletios Therapeutics S.A.S.. (2/28/22). "Press Release: Meletios Therapeutics Signs an Exclusive License Agreement with the Institut Pasteur for the Development of a New Class of Antivirals". Paris....
- [3] AiCuris Anti-infective Cures AG. (2/9/22). "Press Release: AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-acting RNA-based Therapy against BK Virus". Wuppertal & Leiden....
- [4] Leyden Laboratories B.V.. (1/25/22). "Press Release: Leyden Labs Raises $200M in 2021 for a New Approach to Combat Viruses". Amsterdam & Boston, MA....
- [5] Marinomed Biotech AG. (1/21/22). "Press Release: Marinomed Announces the Appointment of Dr. Cornelia Kutzer as Chief Business Officer". Korneuburg....
- [6] Pneumagen Ltd.. (1/19/22). "Press Release: Pneumagen Raises £3.8 million to Advance the Phase II Clinical Development of Neumifil, a Pan-antiviral, Intranasal Drug for the Prophylaxis and Treatment of Viral Respiratory Tract Infections (RTIs)". St Andrew...
- [7] Leyden Laboratories B.V.. (1/18/22). "Press Release: Leyden Labs Licenses Pan-Influenza Antibody from Janssen". Amsterdam & Boston, MA....
- [8] BioNTech SE. (1/11/22). "Press Release: BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants". Mainz & London....
- [9] Molecular Partners AG. (1/10/22). "Press Release: Molecular Partners and Novartis Report Positive Topline Data from Phase 2 Study for Ensovibep (MP0420), a DARPin Antiviral Therapeutic for COVID-19". Zürich-Schlieren & Concord, MA....
- [10] Evotec SE. (1/3/22). "Press Release: Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic". Hamburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top